Optibiotix Health Share Discussion Threads

[lukead] 17/4/2017 15:17

Only to the who deserve it, how's the hsr, directors talk, share prophets doing for any more little gems that you can copy and paste, ho, hi, ho

[incanus] 17/4/2017 14:48

Jezz, dont either of you have some gardening or decorating to do on a bank hol.

[lukead] 17/4/2017 12:23

Congrats you got the name right this time, I was beginning to think you were illiterate as well as daft lol

[lukead] 17/4/2017 12:18

Hey, what's under your sporran Scotty, go on and reveal the secret, the copy and paste wizard. And remember some post's get a double digit green tick even for a simple, "LOL" that's what meaningless rubbish they tend to be on the whole, keep eating he porridge lol

ps, re tick/down ticks, i was merely responding to SM, where he adhered to it, hence my comment 'enemies', possibly wrong word, but who cares, only the likes of you mention it, ' donald, where's your troosers" lol

[lukead] 16/4/2017 23:45

Don't kid anyone proactive, hsr , TW, I did say like, some people !Have a haggis and chips, you old duffer

[scotty1] 16/4/2017 21:23

You think it's HSR think again and it's relating to OPTI and it's from today and yes as most articles are it's summing up what the company is about,and to be quiet honest it's more informative than any of your posts i have read,no your still haven't quite got the hang of wit and sarcasm but hang on in there you you may get there one day but probably not in my life time.Yes you can have the last word as long as your future posts will relate to OPTI (just like you wanted mine to be)but i wont hold my breath and if they are i wouldn't expect to see many posts at all from you.

proactiveinvestors.co.uk/companies/news/176222/materialising-value-for-shareholders-is-the-mantra-for-the-boss-of-life-sciences-firm-optibiotix-176222.html

[lukead] 16/4/2017 18:40

A) Scotty, me old tartan army, I said the other day, I'll be magnanimous and give you the last word.
But that's not good enough for you, my little chipolata, you can not help yourself on Easter Sunday, as well, and wade in with a cheap post. FYI, my last post was a trite remark in reply to a poster of similar stature to yourself and a comment from you was not necessary
B) i am not a member of hot shares rockets or like, as you obviously are, so a copy and paste of one their articles containing rehashed information. which has been said a million times before, is 'beyond my capabilties' (sarcasm) and so I'll leave it to you.
C) I trust you appreciate my acerbic wit and I hope this time old chum, you will do the decent thing and let me have the last word, but i doubt it as knowing how you opertate.
D) COYS, COYS, COYS

[scotty1] 16/4/2017 17:30

Wont let me post link for some reason.


Materialising value for shareholders is the mantra for the boss of life sciences firm Optibiotix
Share
10:26 16 Apr 2017

Stephen O’Hara created Opti as a company all by himself in 2012 as a business focused on the rapidly growing microbiome space, which harnesses the positive benefits of microbes that live on the human body
Microbes
INVESTMENT
OVERVIEW: OPTI
THE BIG
PICTURE
The firm already has commercial partners in place for all its platforms with global brands
Materialising value for shareholders is the mantra for the boss of life sciences firm Optibiotix Health PLC (LON:OPTI), and the recent listing of its skin care business as SkinBioTherapeutics PLC (LON:SBTX) has helped kick that off handsomely.

SkinBioTheraputics made a strong debut when it floated on AIM last on April 5, with the shares rising from an offer price of 9p each to close at 13.25p on the first day of dealings, giving the new firm a value of around £14mln.

‘House’ broker FinnCap, which initiated coverage on Opti at the end of January, pointed out in a note that as it still owns a 41.9% stake in SkinBio after the float that represents around 7% of Opti’s current market cap of about £65mln.


The SkinBio business was created when Opti acquired exclusive rights to intellectual property developed by the University of Manchester around a year ago, and Opti injected £650,000 in to develop the business to give it a 77% holding prior to the float.

So Opti shareholders have clearly seen value created from that move, and chief executive Stephen O’Hara has plans to continue doing that.

O’Hara created Opti as a company all by himself in 2012 as a business focused on the rapidly growing microbiome space, which harnesses the positive benefits of microbes that live on the human body.

Microbiome model …

Opti is focused on using microbiome technology to tackle worldwide health issues such as obesity, high cholesterol and diabetes, and looks to partner up with food, health and pharma companies that have established routes to market to distribute its products.

With the SkinBio spin-off, the group is now focused on three development areas – OptiScreen, which is developing gut bacteria to help in lowering cholesterol; OptiBiotics which is developing SweetBiotix, its natural sweet fibre to help with diabetes control; and Slimbiome, its weight management product.

The firm already has commercial partners in place for all its platforms with global brands.


At the end of 2016, Opti partnered with Indian giant Tata to develop various weight management foods and products that contain its SlimBiome technology.

In March 2016, OptioBiotix also signed a deal with Sacco, one of Europe’s leading probiotic manufacturers and raw ingredients suppliers to manufacture and supply OptiBiotix's cholesterol reducing strain, LPLDL, in Europe.

While it waits to secure further deals, the company is on a steady financial footing. At the end of the last financial year, Opti had around £3mln in the bank and an annual cash burn of around £1.2mln.

To give an idea of the size of the markets Opti is working in, FinnCap analyst Alex Pye estimates that the functional (diet) foods market is worth US$200bn annually.

Further action …

Having created value from the SkinBio spin-off, O’Hara recently told Proactive Investors that his target is to build each of the three divisions into separate legal entities and possibly list each separately on London’s AIM market.


O’Hara said he hoped any listing would be planned sometime by the end of this year and the beginning of next, once each division has built up its IP, development programs, and commercial partnerships.

The firm’s boss also said he plans to give some more of the value from the SkinBio float back to Opti shareholders in the future as well, in a way that is best for both firms.

Overall, O’Hara’s aim is to further the commercialisation phase of the business, increasing revenues organically, but is also exploring the opportunity to make a strategic acquisition as well, which may be the only reason for the firm to raise any further cash, give its healthy balance sheet.

Certainly, Opti has provided shareholders with value, with the stock having jumped to a level of around 80p today against a flotation price in August 2014 of 8p a share.

If its boss can deliver on his plans that value could be very much enhanced.

[scotty1] 16/4/2017 17:28

proactiveinvestors.co.uk/companies/news/176222/materialising-value-for-shareholders-is-the-mantra-for-the-boss-of-life-sciences-firm-optibiotix-176222.html

glad to see lukhead still posting things relevant to OPTI ;))

[ironman22] 16/4/2017 15:45

Portrush, all your post demonstrates is that clearly you haven't got the first clue as to my longs,shorts or any other of my investments and I find it very sad and pathetic that just because someone has posted something you don't like you have to resort to the accusation that I must have multiple usernames. Incorrect again.

[lukead] 16/4/2017 12:31

reminds me, dentist next month, thanks old bean, COYS

[diamond fibre] 16/4/2017 10:41

Can any one see how our products could be used in the dental industry?

[portrush] 16/4/2017 09:09

Ironman has clearly shorted the Ftse...bet he's doing the rounds of the boards under many disguises.See his type all the time.

[aspex] 16/4/2017 08:34

For g*ds sake, cut the cr*p.It's imbecilic!

[judijudi] 16/4/2017 07:47

How's about somebody starts a NK v USA thread?

[john henry] 15/4/2017 23:08

ironman they have had nuclear weapons capability for a long time just unable to merge with a warhead to create a missile.
Markets will react, of cause they will. Some stocks will benifit, some will loose and some wont do a lot.
No more from me.

[ironman22] 15/4/2017 22:30

They might not have the capabilities to fire a nuclear missile to reach the us but they have nuclear weapons and are more than capable of striking South Korea. Kim Jong Un is a lunatic, he doesn't care about his people and would rather go to war than give up his nuclear ambitions. That's all I'll say on the matter but I think I can safely say the markets will react on Tuesday.

[krobertson878] 15/4/2017 22:02

john henry - well said

[john henry] 15/4/2017 21:53

krobertson NK dont have the capabilities yet, Chinese sanctions would bring NK to its knees.
Dont we have this every few years. Imho China needs to start dealing with the situation instead of these half hearted measures that have had very little effect over the past upteen years.
NK is a tiny country that could be crippled with sanctions. Unfortunately it would be the civilians of NK that would suffer.
Anyway thats enough from me on the topic as this is the OPTI board.

[krobertson878] 15/4/2017 21:44

Do we really think USA will allow them to develop something cabable of reaching their shores? No smoke without fire here I think. This is getting extremely serious now. Question is what does China do? Interesting times. Markets looking toppy anyway this might just be the catalyst for a pull back before higher still. If NK launches something nuclear at the USA this could get extremely messy.

[john henry] 15/4/2017 20:53

ironman i think your being a little tramatic at this point in time.

NK are doing this all the time. they love to boast and show off to the Americans.

Im guessing at some point in the future they will have developed a nuclear warhead as with many other countries.